404 related articles for article (PubMed ID: 33718054)
1. Molecular biomarkers in early stage lung cancer.
Rodríguez M; Ajona D; Seijo LM; Sanz J; Valencia K; Corral J; Mesa-Guzmán M; Pío R; Calvo A; Lozano MD; Zulueta JJ; Montuenga LM
Transl Lung Cancer Res; 2021 Feb; 10(2):1165-1185. PubMed ID: 33718054
[TBL] [Abstract][Full Text] [Related]
2. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
3. Secondary prevention and treatment innovation of early stage non-small cell lung cancer: Impact on diagnostic-therapeutic pathway from a multidisciplinary perspective.
Pasello G; Scattolin D; Bonanno L; Caumo F; Dell'Amore A; Scagliori E; Tinè M; Calabrese F; Benati G; Sepulcri M; Baiocchi C; Milella M; Rea F; Guarneri V
Cancer Treat Rev; 2023 May; 116():102544. PubMed ID: 36940657
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
[TBL] [Abstract][Full Text] [Related]
5. Do we need to see to believe?-radiomics for lung nodule classification and lung cancer risk stratification.
Khawaja A; Bartholmai BJ; Rajagopalan S; Karwoski RA; Varghese C; Maldonado F; Peikert T
J Thorac Dis; 2020 Jun; 12(6):3303-3316. PubMed ID: 32642254
[TBL] [Abstract][Full Text] [Related]
6. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
[TBL] [Abstract][Full Text] [Related]
7. [Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test].
Sestini S; Boeri M; Marchianò A; Silva M; Calareso G; Galeone C; Sozzi G; Pastorino U
Epidemiol Prev; 2016; 40(1 Suppl 1):42-50. PubMed ID: 26951732
[TBL] [Abstract][Full Text] [Related]
8. Radiological and pathological analysis of LDCT screen detected and surgically resected sub-centimetre lung nodules in 44 asymptomatic patients.
Hu X; Zhao J; Qian H; Du G; Kelly M; Yang H
Eur J Radiol Open; 2016; 3():223-9. PubMed ID: 27579337
[TBL] [Abstract][Full Text] [Related]
9. Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low-Dose Computed Tomography.
Kan CFK; Unis GD; Li LZ; Gunn S; Li L; Soyer HP; Stark MS
Front Oncol; 2021; 11():555331. PubMed ID: 33968710
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening.
Thomas A; Pattanayak P; Szabo E; Pinsky P
Chest; 2018 Dec; 154(6):1284-1290. PubMed ID: 30080997
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer.
Manjunath Y; Upparahalli SV; Suvilesh KN; Avella DM; Kimchi ET; Staveley-O'Carroll KF; Li G; Kaifi JT
Lung Cancer; 2019 Aug; 134():147-150. PubMed ID: 31319973
[TBL] [Abstract][Full Text] [Related]
12. Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.
Verri C; Borzi C; Holscher T; Dugo M; Devecchi A; Drake K; Sestini S; Suatoni P; Romeo E; Sozzi G; Pastorino U; Boeri M
J Thorac Oncol; 2017 Jun; 12(6):922-931. PubMed ID: 28302568
[TBL] [Abstract][Full Text] [Related]
13. [Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants].
Tang W; Wu N; Huang Y; Wang J; Zhao S; Xu Z; Zhang K; Jiang Y; Cai Q; Zhou L; Li M; Tao D; Liu X; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):549-54. PubMed ID: 25327664
[TBL] [Abstract][Full Text] [Related]
14. Biological markers in lung cancer: A clinician's perspective.
Tufman A; Huber RM
Cancer Biomark; 2010; 6(3-4):123-35. PubMed ID: 20660959
[TBL] [Abstract][Full Text] [Related]
15. Delta Radiomics Improves Pulmonary Nodule Malignancy Prediction in Lung Cancer Screening.
Alahmari SS; Cherezov D; Goldgof D; Hall L; Gillies RJ; Schabath MB
IEEE Access; 2018; 6():77796-77806. PubMed ID: 30607311
[TBL] [Abstract][Full Text] [Related]
16. 9G Test
Choe W; Chae JD; Lee BH; Kim SH; Park SY; Nimse SB; Kim J; Warkad SD; Song KS; Oh AC; Hong YJ; Kim T
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33143045
[TBL] [Abstract][Full Text] [Related]
17. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
18. Stage I nonsmall cell lung carcinoma: analysis of survival and implications for screening.
Dominioni L; Imperatori A; Rovera F; Ochetti A; Torrigiotti G; Paolucci M
Cancer; 2000 Dec; 89(11 Suppl):2334-44. PubMed ID: 11147608
[TBL] [Abstract][Full Text] [Related]
19. A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT).
Wang X; Zhi X; Yang Z; Tian H; Li Y; Li M; Zhao W; Zhang C; Wang T; Liu J; Shen D; Zheng C; Zhao D; Yang S; Qi J; Xin H; Stojadinovic A; Avital I; Lee LJ; Rao J; Zhang W
Oncotarget; 2017 Jul; 8(28):45345-45355. PubMed ID: 28514755
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
